Sweet Binders: Carbonic Anhydrase IX in Complex with Sucralose

ACS Medicinal Chemistry Letters
2018.0

Abstract

Carbonic anhydrase IX (CA IX) expression is important for the regulation of pH in hypoxic tumors and is emerging as a therapeutic target for the treatment of various cancers. Recent studies have demonstrated the selectivity of sucrose, saccharin, and acesulfame potassium for CA IX over other CA isoforms. Reported here is the X-ray crystal structure of CA IX-mimic in complex with sucralose determined to ∼1.5 Å resolution. Furthermore, this structure is compared to the aforementioned sweetener/carbohydrate structural studies in order to determine active site properties of CA IX that promote selective binding. This structural analysis provides a further understanding of CA IX isoform specific inhibition to facilitate the design of new inhibitors and anticancer drugs.

Knowledge Graph

Similar Paper

Sweet Binders: Carbonic Anhydrase IX in Complex with Sucralose
ACS Medicinal Chemistry Letters 2018.0
“Seriously Sweet”: Acesulfame K Exhibits Selective Inhibition Using Alternative Binding Modes in Carbonic Anhydrase Isoforms
Journal of Medicinal Chemistry 2018.0
Mapping Selective Inhibition of the Cancer-Related Carbonic Anhydrase IX Using Structure–Activity Relationships of Glucosyl-Based Sulfamates
Journal of Medicinal Chemistry 2015.0
“A Sweet Combination”: Developing Saccharin and Acesulfame K Structures for Selectively Targeting the Tumor-Associated Carbonic Anhydrases IX and XII
Journal of Medicinal Chemistry 2020.0
Indanesulfonamides as Carbonic Anhydrase Inhibitors. Toward Structure-Based Design of Selective Inhibitors of the Tumor-Associated Isozyme CA IX
Journal of Medicinal Chemistry 2006.0
Cyclic Secondary Sulfonamides: Unusually Good Inhibitors of Cancer-Related Carbonic Anhydrase Enzymes
Journal of Medicinal Chemistry 2014.0
A novel library of saccharin and acesulfame derivatives as potent and selective inhibitors of carbonic anhydrase IX and XII isoforms
Bioorganic & Medicinal Chemistry 2016.0
Discovery and Characterization of Novel Selective Inhibitors of Carbonic Anhydrase IX
Journal of Medicinal Chemistry 2014.0
Carbonic anhydrase inhibitors: The first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX
Bioorganic & Medicinal Chemistry Letters 2004.0
Structural Basis of Nanomolar Inhibition of Tumor-Associated Carbonic Anhydrase IX: X-Ray Crystallographic and Inhibition Study of Lipophilic Inhibitors with Acetazolamide Backbone
Journal of Medicinal Chemistry 2020.0